Comorbid anxiety is common in patients with bipolar disorder. This comorbidity is associated with increased disease severity and poorer treatment response. A study with lurasidone 20-60 mg/day showed significant efficacy against depressive and anxiety symptoms, regardless of baseline anxiety level.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Results of a systematic review and meta-analysis
Physical activity as a therapeutic approach for depression and anxiety disorders
- Underestimated risk - findings from a US cohort
Heart failure after myocardial infarction
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- From symptom to diagnosis
Abdominal pain – Sprue
- Case Report
76-year-old patient with pustular skin rash
- Sponsored Content: Psoriasis
Dauerhafte Erscheinungsfreiheit auch bei betroffenen speziellen Hautarealen
- Antithymocyte globulin in children with T1D
Old medicine, new hope
- Ginkgo biloba